Stay updated with breaking news from Trade Generics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Monday, Cipla reported a 31.8% year-on-year (YoY) jump in its October-December quarter consolidated net profit at Rs 1,056 crore. It was Rs 801 crore in the year-ago period.
Its large presence in India's branded generic drug market exposes it the most to a risk from trade generics. But other major pharma companies are at risk too
Trade generics are branded medicines that are not promoted to physicians but are directly sold through retailers and distributors. In India, trade generics have a market share of 20% by volume and 5-6% by value, according to data and analytics firm IQVIA. The segment is growing around 14-15% per annum.
Dr Reddy's aims to roll out its trade generics across cities and towns in India, including rural areas. The company said it will work closely with its channel partners to ensure the availability of its products.
Just Dial has ramped up its sales force, making employee expenses front-ended and leading to lower margins. This will improve as the workforce matures, Nuvama said